Literature DB >> 11129318

Minor physical anomalies and obstetric complications in schizophrenia.

T F McNeil1, E Cantor-Graae.   

Abstract

OBJECTIVE: To evaluate the possibility of using congenital minor physical anomalies (MPA) and obstetric complications (OC) as individual-orientated, early life markers signalling increased risk for schizophrenia.
METHOD: Previous findings using Waldrop and colleagues' MPA scale (and additional items) and systematic study of OC history are summarised concerning schizophrenia patients and individuals at heightened genetic risk for schizophrenia.
RESULTS: Significantly increased rates of both MPA and OC are consistently found in patients with schizophrenia. Minor physical anomalies are stable characteristics over time and can be studied efficiently from early childhood onward. Minor physical anomalies predict a variety of mental disorders in normal-risk children, but the predictive efficiency of MPA for schizophrenia in genetic high-risk samples and in the general population is unknown. Obstetric complications predict serious mental disturbance and neurodisorder in genetic high-risk cases, as well as doubling or tripling the individual's risk for schizophrenia in the general population. Obstetric complication results are sensitive to methodology and are best investigated using prospectively recorded information and an efficient OC scale for scoring the information.
CONCLUSIONS: Both MPA and OC should be included in batteries of methods for identifying individuals at an increased risk for schizophrenia. However, increased rates of MPA and OC are not pathognomonic for schizophrenia, but rather characterise individuals at risk of a much broader range of mental and physical abnormality, as well as normality. Minor physical anomalies and OC are not in themselves stigmatising, but their possible identification as markers for 'increased risk for schizophrenia' should be used judiciously. Further research is recommended regarding the MPA and OC patterns related to schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 11129318     DOI: 10.1080/000486700225

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  8 in total

1.  Minor physical anomalies in schizophrenia: a meta-analysis.

Authors:  Seth M Weinberg; Elizabeth A Jenkins; Mary L Marazita; Brion S Maher
Journal:  Schizophr Res       Date:  2006-10-31       Impact factor: 4.939

Review 2.  Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?

Authors:  Michael T Compton; Elaine F Walker
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

3.  Influence of obstetric complication severity on brain morphology in schizophrenia: an MR study.

Authors:  G Bersani; A Quartini; G Manuali; A Iannitelli; D Pucci; F Conforti; C Di Biasi; G Gualdi
Journal:  Neuroradiology       Date:  2009-02-13       Impact factor: 2.804

4.  Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers.

Authors:  John P John; Vikram Arunachalam; Bhuvaneshwari Ratnam; Mohan K Isaac
Journal:  Compr Psychiatry       Date:  2007-10-15       Impact factor: 3.735

5.  MRI study of minor physical anomaly in childhood autism implicates aberrant neurodevelopment in infancy.

Authors:  Charlton Cheung; Grainne M McAlonan; Yee Y Fung; Germaine Fung; Kevin K Yu; Kin-Shing Tai; Pak C Sham; Siew E Chua
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

Review 6.  Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.

Authors:  Daniel R Hanson; Irving I Gottesman
Journal:  BMC Med Genet       Date:  2005-02-11       Impact factor: 2.103

7.  Minor physical anomalies in adults with autism spectrum disorder and healthy controls.

Authors:  Irina Manouilenko; Jonna M Eriksson; Mats B Humble; Susanne Bejerot
Journal:  Autism Res Treat       Date:  2014-03-24

8.  Development and validation of a web-based prediction tool on minor physical anomalies for schizophrenia.

Authors:  Xin-Yu Wang; Jin-Jia Lin; Ming-Kun Lu; Fong-Lin Jang; Huai-Hsuan Tseng; Po-See Chen; Po-Fan Chen; Wei-Hung Chang; Chih-Chun Huang; Ke-Ming Lu; Hung-Pin Tan; Sheng-Hsiang Lin
Journal:  Schizophrenia (Heidelb)       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.